RELIEF THER.H.NA.ST.SF 4/ CH1251125998 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 16.6 mill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -6.99 EUR | 45.63% |
| EPS Diluted: | - EUR | 45.63% |
| Revenues per Share: | 0.43 EUR | -62.29% |
| Book Value per Share: | 3.72 EUR | -64.08% |
| Cash Flow per Share: | -1.25 EUR | -27.00% |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 6.03 EUR | -62.29% |
| Net Income: | -98.18 EUR | 93.31% |
| Operating Cash Flow: | -17.61 EUR | - |
| Cash and Cash Equivalents: | 14.56 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 2.75 | 4.63 |
| P/BV ratio: | 0.32 | 0.54 |
| P/CF Ratio: | -0.94 | -1.59 |
| PEG: | 0.00 | - |
| Earnings Yield: | -591.23% | -351.26% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 16.6 mill. EUR | 27.94 mill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 14.04 mill. | |
Profitability
| Gross Profit Margin: | 71.22% |
| EBIT Margin: | -1,837.03% |
| Net Profit Margin: | -1,627.40% |
| Return on Equity: | -187.99% |
| Return on Assets: | -128.53% |
Financial Strength
| Liquidity I / Cash Ratio: | 210.68% |
| Liquidity II / Quick Ratio: | 227.63% |
| Liquidity III / Current Ratio: | 264.93% |
| Debt / Equity Ratio: | 46.26% |
| Dynam. Debt / Equity Ratio: | -137.19% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
